Literature DB >> 24403214

Downgrading of biopsy based Gleason score in prostatectomy specimens.

Kilian M Treurniet1, Dominique Trudel, Jenna Sykes, Andrew J Evans, Antonio Finelli, Theodorus H Van der Kwast.   

Abstract

AIMS: To assess the frequency and possible causes of downgrading from a Gleason score (GS) 7 at biopsy to a GS ≤6 at radical prostatectomy (RP) in a Canadian referral centre.
METHODS: Data were extracted from diagnostic reports of inhouse biopsies and matching prostatectomy specimens from 2008 to 2011 with a GS 7 at biopsy. Biopsies and corresponding prostatectomy specimens of downgraded cases were reviewed. Pathological features were assessed and possible predictors for downgrading were identified.
RESULTS: Based on pathology reports, 29 (8.9%, 95% CI 5.8% to 11.9%) of the 327 eligible cases were downgraded from biopsy GS 7 to RP GS 6, 72% of them representing a GS ≤6 with tertiary grade 4 at RP. Agreement at review of downgraded RP specimens for Gleason grading was fair and of borderline significance (κ=0.34, 95% CI -0.01 to 0.68, p=0.055) with 65% agreement for tertiary grade. The predominant Gleason grade 4 pattern found in the downgraded biopsies was ill-formed glands. The number of cores with Gleason grade 4 component was found to be the strongest negative predictor of downgrading (prereview OR=0.56 (95% CI 0.39 to 0.80, p=0.002), postreview OR=0.19 (95% CI 0.07 to 0.52, p=0.001)).
CONCLUSIONS: The frequency of GS 7 in biopsies subsequently downgraded in RP is low and is associated with International Society of Urological Pathology modified Gleason grade 4 patterns. Downgrading could be attributed in most cases to the presence of a tertiary Gleason grade 4 pattern in the RP specimen. Inter-observer agreement for the presence of tertiary grade 4 in RP specimens is moderate.

Entities:  

Keywords:  Cancer; Diagnostics; Genitourinary Pathology; Prostate

Mesh:

Year:  2013        PMID: 24403214     DOI: 10.1136/jclinpath-2012-201323

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.

Authors:  Shanshan Zhao; Milan S Geybels; Amy Leonardson; Rohina Rubicz; Suzanne Kolb; Qingxiang Yan; Brandy Klotzle; Marina Bibikova; Antonio Hurtado-Coll; Dean Troyer; Raymond Lance; Daniel W Lin; Jonathan L Wright; Elaine A Ostrander; Jian-Bing Fan; Ziding Feng; Janet L Stanford
Journal:  Clin Cancer Res       Date:  2016-06-29       Impact factor: 12.531

2.  Gleason Grade Group Concordance between Preoperative Targeted Biopsy and Radical Prostatectomy Histopathologic Analysis: A Comparison Between In-Bore MRI-guided and MRI-Transrectal US Fusion Prostate Biopsies.

Authors:  Daniel N Costa; Qi Cai; Yin Xi; Debora Z Recchimuzzi; Naveen Subramanian; Aditya Bagrodia; Neil M Rofsky; Claus G Roehrborn; Brad Hornberger; Rajal B Shah; Kenneth Goldberg; Alberto Diaz de Leon; Ivan Pedrosa
Journal:  Radiol Imaging Cancer       Date:  2021-03-05

3.  The impact of surgical downgrading on prostate cancer recurrence: systematic review and analysis of a multiethnic population.

Authors:  Denzel Zhu; William Shyr; Michelle Toker; Ethan Fram; Jinrong Cheng; Evan Z Kovac; Ilir Agalliu; Ahmed Aboumohamed; Kara L Watts
Journal:  World J Urol       Date:  2021-11-30       Impact factor: 4.226

4.  Exploration on Gleason score variation trend of patients with prostate carcinoma from 1996 to 2019: a retrospective single center study.

Authors:  Weiyu Zhang; Gongwei Wang; Fengling Lan; Huanrui Wang; Danhua Shen; Kexin Xu; Tao Xu; Hao Hu
Journal:  Gland Surg       Date:  2021-02

5.  Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.

Authors:  Renan A Pereira; Roberto S Costa; Valdair F Muglia; Fábio Franca Silva; Joyce S Lajes; Rodolfo B Dos Reis; Gyl Eb Silva
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

6.  A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.

Authors:  Dean A Troyer; Tamara Jamaspishvili; Wei Wei; Ziding Feng; Jennifer Good; Sarah Hawley; Ladan Fazli; Jesse K McKenney; Jeff Simko; Antonio Hurtado-Coll; Peter R Carroll; Martin Gleave; Raymond Lance; Daniel W Lin; Peter S Nelson; Ian M Thompson; Lawrence D True; James D Brooks; Jeremy A Squire
Journal:  Prostate       Date:  2015-05-04       Impact factor: 4.104

7.  What is the consistency between the results of needle biopsy and prostatectomy specimen pathology results? A pilot study

Authors:  Ömer Ozan Yıldızlı; İbrahim Üntan; Deniz Demirci
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

8.  The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.

Authors:  Geert J L H van Leenders; Theodorus H van der Kwast; David J Grignon; Andrew J Evans; Glen Kristiansen; Charlotte F Kweldam; Geert Litjens; Jesse K McKenney; Jonathan Melamed; Nicholas Mottet; Gladell P Paner; Hemamali Samaratunga; Ivo G Schoots; Jeffry P Simko; Toyonori Tsuzuki; Murali Varma; Anne Y Warren; Thomas M Wheeler; Sean R Williamson; Kenneth A Iczkowski
Journal:  Am J Surg Pathol       Date:  2020-08       Impact factor: 6.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.